These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 29654096)

  • 21. Exercise-based cardiac rehabilitation for adults with stable angina.
    Long L; Anderson L; Dewhirst AM; He J; Bridges C; Gandhi M; Taylor RS
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD012786. PubMed ID: 29394453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
    Ekpu VU; Brown AK
    Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation.
    Colquitt JL; Mendes D; Clegg AJ; Harris P; Cooper K; Picot J; Bryant J
    Health Technol Assess; 2014 Aug; 18(56):1-560. PubMed ID: 25169727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis.
    Jordan RE; Majothi S; Heneghan NR; Blissett DB; Riley RD; Sitch AJ; Price MJ; Bates EJ; Turner AM; Bayliss S; Moore D; Singh S; Adab P; Fitzmaurice DA; Jowett S; Jolly K
    Health Technol Assess; 2015 May; 19(36):1-516. PubMed ID: 25980984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
    Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
    Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ecologically optimizing exercise maintenance in men and women post-cardiac rehabilitation: Protocol for a randomized controlled trial of efficacy with economics (ECO-PCR).
    Reid R; Blanchard CM; Wooding E; Harris J; Krahn M; Pipe A; Chessex C; Grace SL
    Contemp Clin Trials; 2016 Sep; 50():116-23. PubMed ID: 27475772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Which interventions are cost-effective for the management of whiplash-associated and neck pain-associated disorders? A systematic review of the health economic literature by the Ontario Protocol for Traffic Injury Management (OPTIMa) Collaboration.
    van der Velde G; Yu H; Paulden M; Côté P; Varatharajan S; Shearer HM; Wong JJ; Randhawa K; Southerst D; Mior S; Sutton D; Jacobs C; Taylor-Vaisey A
    Spine J; 2016 Dec; 16(12):1582-1597. PubMed ID: 26631759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of cardiac telerehabilitation in patients with coronary artery disease using a personalised patient-centred web application: protocol for the SmartCare-CAD randomised controlled trial.
    Brouwers RW; Kraal JJ; Traa SC; Spee RF; Oostveen LM; Kemps HM
    BMC Cardiovasc Disord; 2017 Jan; 17(1):46. PubMed ID: 28143388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation.
    Hartwell D; Jones J; Baxter L; Shepherd J
    Health Technol Assess; 2011 Apr; 15(17):i-xii, 1-210. PubMed ID: 21473834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Economic evaluations of fall prevention exercise programs: a systematic review.
    Pinheiro MB; Sherrington C; Howard K; Caldwell P; Tiedemann A; Wang B; S Oliveira J; Santos A; Bull FC; Willumsen JF; Michaleff ZA; Ferguson S; Mayo E; Fairhall NJ; Bauman AE; Norris S
    Br J Sports Med; 2022 Dec; 56(23):1353-1365. PubMed ID: 36302631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy.
    Hockenhull J; Elremeli M; Cherry MG; Mahon J; Lai M; Darroch J; Oyee J; Boland A; Dickson R; Dundar Y; Boyle R
    Health Technol Assess; 2012; 16(12):III-IV, 1-110. PubMed ID: 22409877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.
    Connock M; Burls A; Frew E; Fry-Smith A; Juarez-Garcia A; McCabe C; Wailoo A; Abrams K; Cooper N; Sutton A; O'Hagan A; Moore D
    Health Technol Assess; 2006 Jul; 10(24):iii-iv, ix-136. PubMed ID: 16796930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262): clinical effectiveness systematic review and economic model.
    Archer R; Tappenden P; Ren S; Martyn-St James M; Harvey R; Basarir H; Stevens J; Carroll C; Cantrell A; Lobo A; Hoque S
    Health Technol Assess; 2016 May; 20(39):1-326. PubMed ID: 27220829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EOS 2D/3D X-ray imaging system: a systematic review and economic evaluation.
    McKenna C; Wade R; Faria R; Yang H; Stirk L; Gummerson N; Sculpher M; Woolacott N
    Health Technol Assess; 2012; 16(14):1-188. PubMed ID: 22449757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunosuppressive therapy for kidney transplantation in children and adolescents: systematic review and economic evaluation.
    Haasova M; Snowsill T; Jones-Hughes T; Crathorne L; Cooper C; Varley-Campbell J; Mujica-Mota R; Coelho H; Huxley N; Lowe J; Dudley J; Marks S; Hyde C; Bond M; Anderson R
    Health Technol Assess; 2016 Aug; 20(61):1-324. PubMed ID: 27557331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.
    Papaioannou D; Rafia R; Rathbone J; Stevenson M; Buckley Woods H; Stevens J
    Health Technol Assess; 2012; 16(37):1-253, iii-iv. PubMed ID: 23021127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylactic removal of impacted mandibular third molars: a systematic review and economic evaluation.
    Hounsome J; Pilkington G; Mahon J; Boland A; Beale S; Kotas E; Renton T; Dickson R
    Health Technol Assess; 2020 Jun; 24(30):1-116. PubMed ID: 32589125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does a home-based strength and balance programme in people aged > or =80 years provide the best value for money to prevent falls? A systematic review of economic evaluations of falls prevention interventions.
    Davis JC; Robertson MC; Ashe MC; Liu-Ambrose T; Khan KM; Marra CA
    Br J Sports Med; 2010 Feb; 44(2):80-9. PubMed ID: 20154094
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.